Search

1222498
1230819
1201004
1195994
393884
ScimathUS
The South African Tuberculosis Vaccine Initiative will be offering a limited number of bursaries to cover the Registration Fees associated with the SciMathUS Program, a university preparation program which is offered by the Stellenbosch University...
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...

News

Wednesday, 19 September 2018
Postdoctoral Vacancy: TB Vaccine Trial Immunology

The South African Tuberculosis Vaccine Initiative invites applications for a Postdoctoral Fellowship to conduct research on the Immunology of TB vaccines. NOW CLOSED.

Publication Date:
Friday, April 6, 2018 - 15:00
Latest Research: Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial

SATVI researchers have published an article titled: "Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial"  appearing in the latest Lancet Respiratory Medicine.

Publication Date:
Saturday, March 24, 2018 - 09:45
23 March 2018 TB under the Spotlight Science Engagement launched

On the eve of World TB Day we launched the "TB under the Spotlight Science Engagement" initiative in Worcester in partnership with the Division of Molecular Biology and Human Genetics at the University Stellenbosch and the Department of Education on Tuesday 20 March 2018.

 

Publication Date:
Thursday, March 22, 2018 - 21:45
20 March 2018 Focus on TB: Read about fight against TB in Cape Winelands

Read the latest news about the fight against TB in the Cape Winelands.

Publication Date:
Monday, March 19, 2018 - 19:30

Pages